BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carbamazepine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Carbamazepine\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07939594-4333@assetmemo.bio
DTSTAMP:20261121T004958Z
DTSTART;VALUE=DATE:20270312
DTEND;VALUE=DATE:20270313
SUMMARY:Carbamazepine: Phase 1 readout est. (NCT07939594)
DESCRIPTION:Carbamazepine\, phase 1.\nStudy: An Evaluation of the Potential
  for VH4011499 Drug-drug-interactions\nEstimated primary completion: 12 Ma
 rch 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/carbamazepi
 ne#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 7939594
URL:https://assetmemo.bio/drug/carbamazepine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
